Stockholm, Sweden – memLAYER™, one of Layerlab’s core products, is a chemistry kit that provides biosensor users with a unique approach of immobilizing biological membranes to biosensor surfaces. This enables easier analysis of membrane protein functionality, saving both time and money in the process of drug development.

“Attana is continually striving for collaborations that lead to innovative and efficient applications for our customers. Layerlab’s immobilization technology compliments Attana’s biosensors and offers our customers easier and faster applications for studies of molecular interactions.” says Teodor Aastrup, CEO and founder of Attana.

”Attana is a considerable actor on the biosensor market and we are pleased that memLAYER™ will now be utilized on Attana’s QCM biosensors. The collaboration will lead to increased areas of use for memLAYER™ and supports our strategi to globally increase our local presence on the biosnesor market.” says Torbjörn Pettersson CEO Layerlab AB.